Titlebook: Ovarian Cancers; Advances through Int Eric Pujade-Lauraine,Isabelle Ray-Coquard,Fabrice Book 2017 Springer International Publishing Switze

hair-bulb

通知

collaborative groups such as the GINECO group in France and theirintegration in wider clinical research networks at the European (ENGOT) andinternational (GCIG) level..978-3-319-81199-4978-3-319-32110-3

增强

evaculate

闪光你我

宽大

屈尊

Serous Tumors of Low Malignant Potential and Low-Grade Serous Carcinomas of the Ovary or Peritoneummotherapy, hormonal therapy, and targeted agents such as bevacizumab. MEK inhibitor therapy has had promising activity in a phase II trial, and multiple phase III trials of MEK inhibitor therapy for recurrent low-grade serous carcinoma are ongoing.

难解

圣歌

Cupping